NCT03236740View on ClinicalTrials.gov

OCP vs Metformin on Ovarian Stromal Blood Flow in PCOS

PHASE4CompletedINTERVENTIONAL
Enrollment

101

Participants

Timeline

Start Date

August 1, 2017

Primary Completion Date

March 1, 2018

Study Completion Date

March 15, 2018

Conditions
PCOS
Interventions
DRUG

Ethinyl Estradiol-cyprosterone acetate

Ethinyl Estradiol-cyprosterone acetate in the form of OCPs will be taken cyclically by the participants.

DRUG

Metformin Hydrochloride

Metformin Hydrochoride in the form of 500 mg tablets will be taken twice daily by participants.

Trial Locations (1)

753007

SCB Medical College, Cuttack

All Listed Sponsors
lead

S.C.B. Medical College and Hospital

OTHER

NCT03236740 - OCP vs Metformin on Ovarian Stromal Blood Flow in PCOS | Biotech Hunter | Biotech Hunter